Yahoo Finance

EMBLOK Announces Enrollment of 50th Patient in Clinical Trial for Emblok™ Embolic Protection System for use in TAVR Procedures, Appoints Scientific and Strategic Advisory Board

Medical device company marks trial milestone in the evaluation of its embolic protection device, creates expert advisory board as it navigates growth opportunity TAMPA, Fla., Oct. 8, 2024 /PRNewswire/ ...
Business Insider

Innovative Cardiovascular Solutions Announces Successful First Cases in European Clinical Study of its Next Generation EMBLOK™ Embolic Protection System

MILAN, March 2, 2021 /PRNewswire/ -- Innovative Cardiovascular Solutions (ICS), a privately held medical device company developing the most complete comprehensive solution to embolic protection for ...
KXAN

EMBLOK Announces Enrollment of 50th Patient in Clinical Trial for Emblok™ Embolic Protection System for use in TAVR Procedures, Appoints Scientific and Strategic Advisory Board

Medical device company marks trial milestone in the evaluation of its embolic protection device, creates expert advisory board as it navigates growth opportunity TAVR, a transcatheter procedure, ...
Business Insider

Innovative Cardiovascular Systems Announces First Use of its Next-Generation Emblok™ Embolic Protection System in European Feasibility Study

KALAMAZOO, Mich., March 5, 2019 /PRNewswire/ -- Innovative Cardiovascular Solutions, LLC (ICS), a privately held medical device company, today announced the first clinical use of its next-generation ...